From April 24 to 26, 2025, Toda Pharma participated in ExpoMed Eurasia, Turkey’s largest medical trade show. This major event brings together more than 700 exhibitors and 26,000 visitors, serving as a true regional hub for innovation in medical technology.
ExpoMed Eurasia: A Eurasian Hub for Medical Technologies
Located in Istanbul, ExpoMed Eurasia 2025 has become a must-attend event for healthcare professionals in Europe and Asia. The trade show brings together key players: distributors, hospitals, private laboratories, public institutions, and innovative startups.
The diversity of exhibitors and visitors highlights the importance of this forum for sharing advancements in medical diagnostics,healthcare equipment, and digital solutions.
For Toda Pharma, this edition was a unique opportunity to showcase our range of rapid diagnostic tests, specifically designed for drug and alcohol screening, tailored to local needs while adhering to international standards.
Provide reliable solutions tailored to local challenges
During the trade show, our team had the opportunity to engage directly with specialized distributors, hospitals, testing laboratories, and healthcare institutions looking for high-performance, easy-to-deploy solutions.
Our strength lies in an offering that combines French quality, test performance, and compliance with international standards. These features meet the growing expectations of Eurasian markets for rapid, accurate, and easy-to-use diagnostics.
These solutions are designed for a variety of applications: hospital screenings, workplace testing, public health prevention, and public safety.
A highlight of meaningful discussions and promising collaborations
ExpoMed Eurasia 2025 also served as a venue for meaningful meetings and exchanges. At our booth, we welcomed many visitors interested in our products, eager to form partnerships or explore joint projects.
This trade show fostered the emergence of concrete opportunities in terms of distribution, user training, andmarket expansion in the region.
This momentum underscores the importance of Toda Pharma as a key player committed to the dissemination of cutting-edge technologies for rapid medical diagnostics across Eurasia.
Conclusion: Toward Sustainable Diagnostic Innovation in Eurasia
Toda Pharma's participation in ExpoMed Eurasia 2025 confirms our commitment to supporting healthcare professionals in their diagnostic challenges with tailored, reliable, and innovative solutions.
We warmly thank all the visitors and partners we met in Istanbul and reaffirm our commitment to working together to develop effective solutions to the growing public health needs in the Eurasian region.